康沣生物-B中期报告 2025

康灃生物科技（上海）股份有限公司Cryofocus Medtech (Shanghai) Co., Ltd. （於中華人民共和國註冊成立的股份有限公司）股份代號：6922 2451927282930313244 公司資料 ACGHKACG 339915 33191901 97927 131 1681216 公司資料 6922 H 183171712-1716 www.cryofocus.com 20221230 14412 2 財務摘要 •202463019.5202563051.131.6162.4%20253 •202463056.0202563027.228.851.4% •2025320255 •20258 管理層討論及分析 I. 2013(i)(ii)NOTES NOTES142025630112025630 1. 201910202272023122024120249 2.Cryofocus CryofocusCryofocusCryofocus 2 0 2 21 2CryofocusCryofocus2027 3. 2029 1. 2023320252026 2. 202332025720252026 3. 20214202452025320255 4. 2024120272027 5. 202563020262027 6. 202563020272028 7. 202563020252026 8. 20231220241202412024920258 1. 20171120226202212 2. 202563020252026 3. 202563020252027 1. CT 201932019520191CE20243 2. 2020620228202210 3. 201722017420191CE 4.(PFA) (PFA)PFA 2025630PFA2027 5. 20256302025 6. 20256303316 202563015360 14,400 •••• II. 202463019.5202563051.131.6162.4%20253 20246304.2202563016.82025 202463015.3202563034.3202463078.5%202563067.1% 20246303.020256300.5 (i)(ii)(iii)(iv) 202463037.2202563017.919.351.9%(i)8.7(ii)7.0 202463033.2202563033.70.51.7% 20246303.320256309.25.8174.4% 20246300.420256301.10.7142.0% 25%15%2024 Cryofocus America, Inc.21% 202463056.0202563027.2 2024123145.5202563063.718.240.1% •20256306.9 •20256300.1•202563025.3 20256303.45%3.50%25.7202430.0 202563025.7 (1)(2)(3)100% 2025630 630 2025630 2025630 2025630180202563042.3(i)(ii)(iii) 其他資料 2024630 2025630 3.10(2) 2025630 2025219GEM8080 13.51B(1) 13.2013.2113.22 其他資料 2025630XVXV78352 (1)2025630239,110,000 (3)20256301,030,697441,727H202563038.77%8,690,5393,724,517H (4)20256304,373,99817,495,990H202563037.22%8,972,7123,845,448H2021426201411202563097,600H202563065%2025630202563049.02%76,060,09235,017,176H 2025630352 2025630XV23336 (1)2025630239,110,000 (2)202563095,671,421143,438,579H (3)202142620141120256304,373,99817,495,990H202563037.22%8,972,7123,845,448H202563097,600H202563065%2025630202563049.02%20256307,873,000H76,060,09242,890,176H (4)202563044,538,29519,087,841H202563021,519,8259,222,783H202563049.02%2,419,992H (5)202563010,001,9724,286,560H202563065%66,058,12030,730,616H (6)20256301,030,697441,727H202563038.77%8,690,5393,724,517H (7)55%50.11%36.42%9,669,4809,647,080H (8)99%12,283,500H (9)90%3,782,40611,830,350H (10)FutureXInvestment I Company LimitedFutureXICT Opportunity Fund II LPFutureX ICTOpportunityFund II LPFutureX Innovation II LimitedFutureX Innovation II LimitedFutureXFundManagement(HongKong)LimitedFutureXICTOpportunityFundIILPFutureXFundManagement(HongKong)LimitedFutureXCapitalLimitedFutureXCapitalLimitedFutureXICTOpportunityFundIILPFutureXInnovationIILimited FutureXFundManagement(HongKong)LimitedFutureXCapitalLimitedFutureX Investment I Company Limited7,963,128H (11)51%6,072,552H 2025630XV23336 2025331 20256202024202533120256202025429 202588 中期簡明綜合全面收益表截至2025年6月30日止六個月 中期簡明綜合財務狀況表2025年6月30日 中期簡明綜合權益變動表截至2025年6月30日止六個月 中期簡明綜合財務資料附註2025年6月30日 1. 339915 2025630 •• 20221230 中期簡明綜合財務資料附註2025年6月30日 2.1. 20256303420241231 2.2. 20241231 21 21 3. 8 4. (a) 中期簡明綜合財務資料附註2025年6月30日 4. 5. 6. 中期簡明綜合財務資料附註2025年6月30日 7. 25%15% 21% 8. 2024 9. 239,110,0002024630239,110,00020217 20252024630 10. 11. 中期簡明綜合財務資料附註2025年6月30日 12. 13. (a) 13. 中期簡明綜合財務資料附註2025年6月30日 13. 13. (e) 中期簡明綜合財務資料附註2025年6月30日 14. 釋義 1.00%